期刊
INTERNATIONAL JOURNAL OF CANCER
卷 153, 期 5, 页码 958-968出版社
WILEY
DOI: 10.1002/ijc.34574
关键词
borderline ovarian tumors; cohort study; ovarian cancer; polycystic ovary syndrome
类别
There is a potential association between polycystic ovary syndrome (PCOS) and epithelial ovarian tumors due to shared risk factors. However, previous studies have shown conflicting results and methodological limitations. A population-based cohort study in Denmark was conducted to investigate this association. While there was no overall association, postmenopausal women with PCOS had an increased risk of ovarian cancer and women with PCOS had an increased risk of serous borderline ovarian tumors compared to those without PCOS. Larger studies with longer follow-up are needed to confirm these findings.
An association between polycystic ovary syndrome (PCOS) and epithelial ovarian tumors is biologically plausible as conditions inherent to PCOS such as excessive androgenic hormones, reproductive factors and obesity are also risk factors for these hormone-sensitive tumors. However, previous studies have showed conflicting results and have various methodological limitations. This population-based cohort study investigates the association between PCOS and epithelial ovarian tumors and includes all women born in Denmark between January 1, 1940 and December 31, 1993 (n = 1 719 304). PCOS diagnoses, ovarian cancer and borderline ovarian tumor diagnoses, covariates, migration and vital status were obtained from the Danish national registers. Adjusted cox proportional hazard regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CI) for epithelial ovarian cancer and for borderline ovarian tumors overall as well as for histological subtypes separately. During median 26 years of follow-up we identified 6490 women with ovarian cancer and 2990 women with borderline ovarian tumors. Overall, we observed no marked associations between a diagnosis of PCOS and overall epithelial ovarian cancer or overall epithelial borderline ovarian tumors, irrespective of time since diagnosis. However, we found an increased risk of ovarian cancer among postmenopausal women with PCOS (HR 2.28 95% CI 1.02-5.09) and an increased risk of serous borderline ovarian tumors (HR 2.34 95% CI 1.21-4.53) in women with PCOS compared with women without PCOS. Importantly, low statistical precision is a crucial limitation of our study and in previous studies and larger studies with longer follow-up are therefore warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据